Products
Preparation registered in Ukraine
Combined use of drugs Adenorm and Alpha-lipon to optimize treatment of patients with BPH and PSA level of “gray scale”
Rossikhin V., Khoschenko Y., Bukhmin A.
Some specific of treatment patients with lower urinary tract symptoms (LUTS) combined with prostatic obstruction set conditions of tactical problem in patients with ratio prostate specific antigen (PSA) level between 4 and 10 ng/mL in serum blade. Effectiveness of combination of alpha1AD adrenergic blocking agent Adenorm (tamsulosin) with antioxidant Alfa-lipon (lipoic acid) in patients with BPH and PSA 4–10 ng/ml, during 60 days had been proven. Combined therapy (Adenorm with Alfa-lipon) has positive effect at visual and on objective symptoms of BPH. The trial results allow to recommend the complex Adenorm + Alfa-lipon for moderately BPH patients and average PSA level incretion.
Key worlds: BPH, tamsulosin, prostate specific antigen.